-
As Cannabis Use Grows Among Cancer Patients, Federal Agency Highlights Need For Rescheduling
Thursday, October 17, 2024 - 3:31pm | 620As cannabis legalization continues to expand across the U.S., its use among cancer patients has also increased significantly, particularly for managing symptoms like nausea, pain, anxiety and insomnia. A recent blog entry from Carmen Phillips at the National Cancer Institute (NCI), a part of...
-
Multivitamins Show No Link To 'Lower Risk of Death,' Study Finds
Thursday, June 27, 2024 - 4:01pm | 489Taking a multivitamin once a day has long been considered a path to better health, but a new study refutes that widely held belief. A study published in JAMA Network Open on Wednesday revealed that after tracking nearly 400,000 healthy adults for over 20 years, researchers found no link between...
-
In Less Than 2 Months, Federal Health Agency Has Granted $6.4M To Study Medical Marijuana In Cancer Patients
Friday, November 10, 2023 - 10:52am | 796The National Cancer Institute (NCI), recently awarded $3.2 million to researchers studying the effects of medical marijuana in breast cancer treatment. The University of Florida Health Center reported that scientists hypothesize that medical marijuana could improve...
-
New Study: Morphine Use Among Cancer Patients Linked To Bone Loss And Pain, Is Medical Marijuana An Option?
Friday, July 7, 2023 - 7:56pm | 809University of Arizona Health Sciences researchers have found that chronic morphine use may contribute to bone loss and heightened pain, according to a study published in PAIN. While opioids like morphine are commonly used to manage cancer-induced bone pain, the findings shed light on the potential...
-
Which Pharma Players Dominate The Lung Cancer Space?
Wednesday, January 25, 2017 - 3:40pm | 946Lung and bronchus cancer is the leading cause of cancer deaths in the United States, according to the National Cancer Institute. Lung cancer is of two types, namely non-small cell lung cancer, or NSCLC and small cell lung cancer, or SCLC, with the former more prevalent than the latter. Estimates by...
-
Kite Pharma Falls 6%, Co. Confirms Review Of All Facilities Involving Sterile Material
Monday, April 18, 2016 - 10:21am | 154Shares of Kite Pharma Inc (NASDAQ: KITE) were trading lower by more than 6 percent Monday morning after the clinical-stage bio-pharmaceutical company confirmed that its facilities are undergoing a voluntary review. Kite Pharma said its cell therapy manufacturing facilities at the National Cancer...